Receptors, Vasoactive Intestinal Peptide, Type II
"Receptors, Vasoactive Intestinal Peptide, Type II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pituitary adenylate cyclase-activating peptide receptor subtype found in LYMPHOCYTES. It binds both PACAP and VASOACTIVE INTESTINAL PEPTIDE and regulates immune responses.
| Descriptor ID |
D051239
|
| MeSH Number(s) |
D12.776.543.750.695.665.750 D12.776.543.750.695.900.500
|
| Concept/Terms |
Receptors, Vasoactive Intestinal Peptide, Type II- Receptors, Vasoactive Intestinal Peptide, Type II
- VIP2 Receptors
- Receptors, VIP2
- VPAC2 Receptor
- Receptor, VPAC2
- Vasoactive Intestinal Peptide 2 Receptor
- PACAP Type III Receptor
- PACAPR-3 Protein
- PACAPR 3 Protein
- Vasoactive Intestinal Peptide Receptor 2
- Pituitary Adenylate Cyclase-Activating Peptide Receptor Type III
- Pituitary Adenylate Cyclase Activating Peptide Receptor Type III
- PACAP Receptors, Type III
- VIP Receptors, Type II
- Vasoactive Intestinal Peptide Receptors, Type II
- Receptors, Pituitary Adenylate Cyclase-Activating Peptide, Type III
- VIP2 Receptor
- Receptor, VIP2
- VIPR2 Protein
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Vasoactive Intestinal Peptide, Type II".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide [D12.776.543.750.695.665]
- Receptors, Vasoactive Intestinal Peptide, Type II [D12.776.543.750.695.665.750]
- Receptors, Vasoactive Intestinal Peptide [D12.776.543.750.695.900]
- Receptors, Vasoactive Intestinal Peptide, Type II [D12.776.543.750.695.900.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Vasoactive Intestinal Peptide, Type II".
This graph shows the total number of publications written about "Receptors, Vasoactive Intestinal Peptide, Type II" by people in this website by year, and whether "Receptors, Vasoactive Intestinal Peptide, Type II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Vasoactive Intestinal Peptide, Type II" by people in Profiles.
-
Cross-talk between fetal membranes and visceral adipose tissue involves HMGB1-RAGE and VIP-VPAC2 pathways in human gestational diabetes mellitus. Acta Diabetol. 2019 Jun; 56(6):681-689.
-
CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci U S A. 2018 06 12; 115(24):6261-6266.
-
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System. Int J Mol Sci. 2018 Mar 25; 19(4).